Canaccord analyst Richard Close noted Politico published an article stating that NYC will be declining to renew the DocGo migrant services contract that is coming to the end of the 1-year term in early May. The company will continue providing services for roughly1,800 migrants in upstate New York, noting the Mayor’s office is working with the comptroller’s office on a temporary extension for that part of the contract. Canaccord said they would not view this contract being awarded away from DocGo to necessarily be a bad outcome given all the negative headlines investors have endured over the last nearly 10 months. They believe it could be viewed as a long-term positive, assuming the pipeline of new mobile health business opportunities outside of NYC migrant work is as robust as communicated. Canaccord maintains its Buy rating and $10 price target on DocGo shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCGO:
- DocGo’s Subsidiary Renews NYC Asylum Seeker Support Contract
- DocGo CFO bought 10,000 shares at $3.61 per share on March 14
- DocGo enters 10b5-1 trading plan for additional $10M stock repurchase program
- DocGo Announces Leadership Shuffle and New Board Chair
- 3 Best Stocks to Buy Now, 3/1/2024, According to Top Analysts